{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T11:45:01Z","timestamp":1785843901517,"version":"3.56.0"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"44","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,11,1]]},"abstract":"<jats:p>\n                    Cholecystectomy generally has no adverse effects on health. Studies demonstrating the association between metabolic diseases and long-term effects of cholecystectomy are increasing. preperitoneal fat thickness (PFT) is an important indicator of metabolic syndrome. Metabolic syndrome is a risk factor for sarcopenia. The aim of our study was to investigate the relationship between cholecystectomy and sarcopenia-visceral fat using the ISarcoPRM algorithm, which is an easy, reliable, and inexpensive method based on ultrasound measurement, to evaluate sarcopenia in patients with long-term previous cholecystectomy. This cross-sectional study included participants who had undergone cholecystectomy at least 5 years ago and a control group with similar characteristics. Sarcopenia was assessed using the ISarcoPRM algorithm, incorporating the sonographic thigh adjustment ratio (STAR), grip strength, and chair stand test (CST). Together with low STAR values (&lt;1.0 for females and &lt;1.4 for males), ow grip strength (&lt;19\u2009kg for females or &lt;32\u2009kg for males), and\/or prolonged CST duration (\u226512 seconds) were used to diagnose sarcopenia. Ultrasound was used to measure the visceral fat thickness. The investigation of sarcopenia and PFT values between individuals with and without cholecystectomy was planned. A total of 158 participants were included, including 89 post-cholecystectomy patients and 69 controls. Binary regression analysis revealed that cholecystectomy was positively associated with sarcopenia (OR\u2005=\u20052.788, 95% CI: 1.054\u20137.375,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.039). However, when PFT was included, it was independently associated with sarcopenia (OR\u2005=\u20051.157, 95% CI: 1.067\u20131.254,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;\u2005.001), and the relationship with cholecystectomy disappeared (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&gt;\u2005.05). PFT values of 10.0\u2009mm or higher were associated with 5.875 times (95% CI: 2.035\u201316.961,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.001) increased odds of sarcopenia. Sarcopenia was 2.8 times more frequent in patients who had undergone cholecystectomy than in those who had not, but this relationship was mediated by increased PFT. The risk of sarcopenia increased up to 5.875 times when the PFT exceeded 10\u2009mm.\n                  <\/jats:p>","DOI":"10.1097\/md.0000000000040355","type":"journal-article","created":{"date-parts":[[2024,11,4]],"date-time":"2024-11-04T16:04:24Z","timestamp":1730736264000},"page":"e40355","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Strong association between sarcopenia and visceral fat in the long term after cholecystectomy: A cross-sectional study using the ISarcoPRM algorithm"],"prefix":"10.1097","volume":"103","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0458-1450","authenticated-orcid":false,"given":"Semih","family":"Sezer","sequence":"first","affiliation":[{"name":"Department of Gastroenterology, Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital, Ankara, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selim","family":"Demirci","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital, Ankara, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d6zg\u00fcr","family":"Kara","sequence":"additional","affiliation":[{"name":"Department of Geriatric Medicine, Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital, Ankara, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murat","family":"Kara","sequence":"additional","affiliation":[{"name":"Department of Physical and Rehabilitation Medicine, Hacettepe University Medical School, Ankara, Turkey."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260804","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.bpg.2006.05.004","article-title":"Gallstone disease: epidemiology of gallbladder stone disease.","volume":"20","author":"Shaffer","year":"2006","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"R2-20260804","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/hep.1840210109","article-title":"Long-term effects of cholecystectomy on bile acid metabolism.","volume":"21","author":"Kullak-Ublick","year":"1995","journal-title":"Hepatology"},{"key":"R3-20260804","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S1665-2681(19)31490-5","article-title":"Association between cholecystectomy for gallstone disease and risk factors for cardiovascular disease.","volume":"11","author":"Chavez-Tapia","year":"2012","journal-title":"Ann Hepatol"},{"key":"R4-20260804","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1038\/ajg.2013.70","article-title":"Relationship of non-alcoholic fatty liver disease with cholecystectomy in the US population.","volume":"108","author":"Ruhl","year":"2013","journal-title":"Am J Gastroenterol"},{"key":"R5-20260804","doi-asserted-by":"crossref","first-page":"G413","DOI":"10.1152\/ajpgi.00435.2012","article-title":"Postprandial gut hormone responses and glucose metabolism in cholecystectomized patients.","volume":"304","author":"Sonne","year":"2013","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"R6-20260804","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1002\/oby.23334","article-title":"Sarcopenia and sarcopenic obesity after cholecystectomy: a population-based study.","volume":"30","author":"Gan","year":"2022","journal-title":"Obesity (Silver Spring)"},{"key":"R7-20260804","first-page":"195","article-title":"Visceral obesity and the metabolic syndrome: effects of weight loss.","volume":"11","author":"Busetto","year":"2001","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"R8-20260804","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/j.1440-1746.2007.05125.x","article-title":"Visceral obesity as a risk factor for colorectal neoplasm.","volume":"23","author":"Oh","year":"2008","journal-title":"J Gastroenterol Hepatol"},{"key":"R9-20260804","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1093\/ageing\/afy169","article-title":"Sarcopenia: revised European consensus on definition and diagnosis.","volume":"48","author":"Cruz-Jentoft","year":"2019","journal-title":"Age Ageing"},{"key":"R11-20260804","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/BF02982704","article-title":"Sarcopenia: its assessment, etiology, pathogenesis, consequences and future perspectives.","volume":"12","author":"Rolland","year":"2008","journal-title":"J Nutr Health Aging"},{"key":"R12-20260804","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1093\/ageing\/afq034","article-title":"Sarcopenia: European consensus on definition and diagnosis: report of the European working group on sarcopenia in older people.","volume":"39","author":"Cruz-Jentoft","year":"2010","journal-title":"Age Ageing"},{"key":"R13-20260804","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1097\/PHM.0000000000001439","article-title":"STAR-Sonographic thigh adjustment ratio: a golden formula for the diagnosis of sarcopenia.","volume":"99","author":"Kara","year":"2020","journal-title":"Am J Phys Med Rehabil"},{"key":"R14-20260804","doi-asserted-by":"crossref","first-page":"jrm00209","DOI":"10.2340\/16501977-2851","article-title":"Diagnosing sarcopenia: functional perspectives and a new algorithm from the ISarcoPRM.","volume":"53","author":"Kara","year":"2021","journal-title":"J Rehabil Med"},{"key":"R15-20260804","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1016\/j.ejrad.2016.04.005","article-title":"Ultrasound: which role in body composition?","volume":"85","author":"Bazzocchi","year":"2016","journal-title":"Eur J Radiol"},{"key":"R16-20260804","doi-asserted-by":"crossref","first-page":"2594","DOI":"10.1210\/en.2003-1671","article-title":"Fibroblast growth factor 19 increases metabolic rate and reverses dietary and leptin-deficient diabetes.","volume":"145","author":"Fu","year":"2004","journal-title":"Endocrinology"},{"key":"R17-20260804","doi-asserted-by":"crossref","first-page":"e12983","DOI":"10.1111\/obr.12983","article-title":"Pathophysiological connections between gallstone disease, insulin resistance, and obesity.","volume":"21","author":"Cort\u00e9s","year":"2020","journal-title":"Obes Rev"},{"key":"R18-20260804","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.2214\/AJR.07.2366","article-title":"Sonographic assessment of regional adiposity.","volume":"189","author":"Vlachos","year":"2007","journal-title":"AJR Am J Roentgenol"},{"key":"R19-20260804","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/nature07205","article-title":"Cancer-related inflammation.","volume":"454","author":"Mantovani","year":"2008","journal-title":"Nature"},{"key":"R20-20260804","first-page":"1489","article-title":"Association of obesity and overweight with overall survival in colorectal cancer patients: a meta-analysis of 29 studies.","volume":"25","author":"Wu","year":"2014","journal-title":"Cancer Causes Control"},{"key":"R21-20260804","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1186\/s12889-023-17275-2","article-title":"Abdominal obesity and digestive system cancer: a systematic review and meta-analysis of prospective studies.","volume":"23","author":"Li","year":"2023","journal-title":"BMC Public Health"},{"key":"R22-20260804","doi-asserted-by":"crossref","first-page":"43551","DOI":"10.1038\/srep43551","article-title":"Waist-hip ratio (WHR), a better predictor for prostate cancer than body mass index (BMI): results from a Chinese hospital-based biopsy cohort.","volume":"7","author":"Tang","year":"2017","journal-title":"Sci Rep"},{"key":"R23-20260804","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/sj.ijo.0801187","article-title":"Preperitoneal fat thickness determined by ultrasonography is correlated with coronary stenosis and lipid disorders in non-obese male subjects.","volume":"24","author":"Tadokoro","year":"2000","journal-title":"Int J Obesity Related Metab Disord"},{"key":"R24-20260804","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1111\/jgh.13903","article-title":"Preperitoneal fat as a non-invasive marker of increased risk of severe non-alcoholic fatty liver disease in patients with type 2 diabetes.","volume":"33","author":"Parente","year":"2018","journal-title":"J Gastroenterol Hepatol"},{"key":"R25-20260804","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1002\/oby.22494","article-title":"Intra-abdominal adipose tissue quantification by alternative versus reference methods: a systematic review and meta-analysis.","volume":"27","author":"Murphy","year":"2019","journal-title":"Obesity"},{"key":"R26-20260804","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1152\/physiolgenomics.00249.2004","article-title":"Identification of a molecular signature of sarcopenia.","volume":"21","author":"Giresi","year":"2005","journal-title":"Physiol Genomics"},{"key":"R27-20260804","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1172\/JCI117936","article-title":"Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance.","volume":"95","author":"Hotamisligil","year":"1995","journal-title":"J Clin Invest"},{"key":"R28-20260804","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s00125-009-1627-x","article-title":"IL6 as a mediator of insulin resistance: fat or fiction?","volume":"53","author":"Allen","year":"2010","journal-title":"Diabetologia"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000040355","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T11:01:05Z","timestamp":1785841265000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000040355"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,1]]},"references-count":27,"journal-issue":{"issue":"44","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000040355","relation":{},"ISSN":["1536-5964"],"issn-type":[{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,1]]}}}